A detailed history of Financial Counselors Inc transactions in Danaher Corp stock. As of the latest transaction made, Financial Counselors Inc holds 111,219 shares of DHR stock, worth $25.7 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
111,219
Previous 110,551 0.6%
Holding current value
$25.7 Million
Previous $27.6 Million 11.93%
% of portfolio
0.46%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$239.25 - $280.76 $159,819 - $187,547
668 Added 0.6%
111,219 $30.9 Million
Q2 2024

Aug 01, 2024

BUY
$235.51 - $267.98 $60,526 - $68,870
257 Added 0.23%
110,551 $27.6 Million
Q1 2024

May 02, 2024

SELL
$224.58 - $256.19 $299,140 - $341,245
-1,332 Reduced 1.19%
110,294 $27.5 Million
Q4 2023

Jan 26, 2024

BUY
$185.1 - $233.13 $199,352 - $251,081
1,077 Added 0.97%
111,626 $25.8 Million
Q3 2023

Nov 07, 2023

BUY
$233.08 - $265.59 $382,950 - $436,364
1,643 Added 1.51%
110,549 $27.4 Million
Q2 2023

Jul 27, 2023

BUY
$224.99 - $256.14 $102,820 - $117,055
457 Added 0.42%
108,906 $26.1 Million
Q1 2023

May 02, 2023

BUY
$239.75 - $277.0 $119,395 - $137,946
498 Added 0.46%
108,449 $27.3 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $151,128 - $176,713
626 Added 0.58%
107,951 $28.7 Million
Q3 2022

Nov 01, 2022

BUY
$247.06 - $1507.4 $29,153 - $177,873
118 Added 0.11%
107,325 $27.7 Million
Q2 2022

Aug 02, 2022

BUY
$237.11 - $299.66 $891,770 - $1.13 Million
3,761 Added 3.64%
107,207 $27.2 Million
Q1 2022

Apr 28, 2022

BUY
$257.27 - $315.76 $1.69 Million - $2.08 Million
6,576 Added 6.79%
103,446 $30.3 Million
Q4 2021

Feb 10, 2022

SELL
$292.08 - $329.01 $4.35 Million - $4.9 Million
-14,898 Reduced 13.33%
96,870 $31.9 Million
Q3 2021

Oct 26, 2021

SELL
$272.21 - $332.43 $3.92 Million - $4.79 Million
-14,402 Reduced 11.41%
111,768 $34 Million
Q2 2021

Aug 03, 2021

SELL
$225.08 - $271.69 $2.44 Million - $2.94 Million
-10,827 Reduced 7.9%
126,170 $33.9 Million
Q1 2021

Apr 29, 2021

SELL
$212.38 - $245.9 $129,764 - $150,244
-611 Reduced 0.44%
136,997 $30.8 Million
Q4 2020

Feb 10, 2021

SELL
$212.5 - $245.46 $330,012 - $381,199
-1,553 Reduced 1.12%
137,608 $30.6 Million
Q3 2020

Nov 16, 2020

BUY
$177.16 - $215.33 $1.51 Million - $1.84 Million
8,551 Added 6.55%
139,161 $30 Million
Q2 2020

Aug 07, 2020

BUY
$128.7 - $176.83 $2.16 Million - $2.96 Million
16,759 Added 14.72%
130,610 $23.1 Million
Q1 2020

Apr 23, 2020

BUY
$121.39 - $169.05 $222,629 - $310,037
1,834 Added 1.64%
113,851 $15.8 Million
Q4 2019

Jan 31, 2020

BUY
$133.47 - $153.48 $423,233 - $486,685
3,171 Added 2.91%
112,017 $17.2 Million
Q3 2019

Nov 08, 2019

BUY
$135.4 - $146.47 $73,386 - $79,386
542 Added 0.5%
108,846 $15.7 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $201,181 - $231,549
1,611 Added 1.51%
108,304 $15.5 Million
Q1 2019

May 10, 2019

BUY
$97.62 - $132.29 $42,659 - $57,810
437 Added 0.41%
106,693 $14.1 Million
Q4 2018

Feb 01, 2019

BUY
$94.85 - $109.54 $7,682 - $8,872
81 Added 0.08%
106,256 $11 Million
Q3 2018

Oct 30, 2018

BUY
$98.13 - $108.9 $48,770 - $54,123
497 Added 0.47%
106,175 $11.5 Million
Q2 2018

Aug 03, 2018

BUY
$96.1 - $103.24 $87,162 - $93,638
907 Added 0.87%
105,678 $10.4 Million
Q1 2018

Apr 26, 2018

SELL
$92.16 - $103.8 $240,261 - $270,606
-2,607 Reduced 2.43%
104,771 $10.3 Million
Q4 2017

Feb 12, 2018

SELL
$85.26 - $94.62 $103,846 - $115,247
-1,218 Reduced 1.12%
107,378 $9.97 Million
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $95,148 - $106,140
1,200 Added 1.12%
108,596 $9.32 Million
Q2 2017

Aug 10, 2017

BUY
N/A
107,396
107,396 $9.06 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.